Sciensano contributes to the fight against tuberculosis by providing rapid diagnosis, by monitoring the antibiotic resistance of bacterial strains, by detecting epidemics, and developing new and more effective vaccines and treatments. The Belgian Official Medicines Control Laboratory (OMCL) of Sciensano, together with the European OMCL network, is responsible for the quality control of the tuberculosis vaccine prior to marketing.
